National and Kapodistrian University of Athens
Μελέτη της επίδρασης των αντιεπιληπτικών φαρμάκων στη σωματική αύξηση, τις ορμόνες λεπτίνη και γκρελίνη και τη συσχέτισή τους με τη θυρεοειδική λειτουργία σε παιδιά με επιληψία
Abstract
dc:descriptionIntroduction: Epilepsy and AEDs affect growth and hormonal balance with unclear pathogenicmechanisms.Aims: To evaluate the effect of oxcarbazepine (OXC) and valproate (VPA) on growth, thyroid function,peptide hormones and lipid profile.Materials-Methods: 59 children, aged 3.7-15.4yrs, 26 on OXC and 33 on VPA monotherapy wereevaluated before, after 8 and 18 months of treatment. Data were analyzed using SPSS 17.0. P<0.05was considered significant.Results: At 8th month, the percentage of overweight/obese children climbed from 23% to 38.5 %(OXC), and from 33.3 % to 54.5 % (VPA). The Δ-SDS-BW, Δ-SDS-BMI and TSH levels were increasedsignificantly, while FT4 levels were decreased in both groups. A significant increase of LDL-cholesterol and γGT levels was demonstrated only in OXC group. Lipoprotein (a), [Lp(a)], was increased in bothgroups. Further increases in obesity rates were noted only in the VPA group at 18 months. The use ofOXC and VPA had no significant effect on Δ-SDS-Height and, the leptin, adiponectin and total-activeghrelin levels. Compared to controls epileptic children had significantly higher leptin and lowertotal/active ghrelin levels.Conclusions: Epileptic children on OXC or VPA monotherapy are at increased risk foroverweight/obesity, hypothyroidism and dyslipidemia. Furthermore, epilepsy may be associated withhigh plasma leptin and low plasma ghrelin levels.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2014
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Koemtzidou, Evangelia
- Κοεμτζίδου, Ευαγγελία
Subjects
dc:subject × 16Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/43678